For examples, Sohn et al. reported that TT genotype of VEGFA rs833061 polymorphism predicted superior ORR (objective response rate) to the first-line cytotoxic chemotherapy combined with bevacizumab among CRC patients in South Korea [21]. Here, VEGFA is linked to colorectal carcinoma.